rs8722

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182972.3(IRF2BP2):​c.991C>T​(p.Leu331=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.212 in 1,608,560 control chromosomes in the GnomAD database, including 38,839 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2668 hom., cov: 33)
Exomes 𝑓: 0.22 ( 36171 hom. )

Consequence

IRF2BP2
NM_182972.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.511
Variant links:
Genes affected
IRF2BP2 (HGNC:21729): (interferon regulatory factor 2 binding protein 2) This gene encodes an interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 1-234608504-G-A is Benign according to our data. Variant chr1-234608504-G-A is described in ClinVar as [Benign]. Clinvar id is 402982.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.511 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.222 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IRF2BP2NM_182972.3 linkuse as main transcriptc.991C>T p.Leu331= synonymous_variant 1/2 ENST00000366609.4
IRF2BP2NM_001077397.1 linkuse as main transcriptc.991C>T p.Leu331= synonymous_variant 1/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IRF2BP2ENST00000366609.4 linkuse as main transcriptc.991C>T p.Leu331= synonymous_variant 1/21 NM_182972.3 P3Q7Z5L9-1
IRF2BP2ENST00000366610.7 linkuse as main transcriptc.991C>T p.Leu331= synonymous_variant 1/21 A1Q7Z5L9-2
ENST00000436039.1 linkuse as main transcriptn.630+867G>A intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
25369
AN:
152106
Hom.:
2671
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0424
Gnomad AMI
AF:
0.242
Gnomad AMR
AF:
0.169
Gnomad ASJ
AF:
0.227
Gnomad EAS
AF:
0.210
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.255
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.225
Gnomad OTH
AF:
0.189
GnomAD3 exomes
AF:
0.189
AC:
45928
AN:
242520
Hom.:
4970
AF XY:
0.192
AC XY:
25291
AN XY:
131958
show subpopulations
Gnomad AFR exome
AF:
0.0345
Gnomad AMR exome
AF:
0.125
Gnomad ASJ exome
AF:
0.231
Gnomad EAS exome
AF:
0.204
Gnomad SAS exome
AF:
0.102
Gnomad FIN exome
AF:
0.255
Gnomad NFE exome
AF:
0.235
Gnomad OTH exome
AF:
0.208
GnomAD4 exome
AF:
0.216
AC:
315187
AN:
1456336
Hom.:
36171
Cov.:
32
AF XY:
0.213
AC XY:
154599
AN XY:
724136
show subpopulations
Gnomad4 AFR exome
AF:
0.0353
Gnomad4 AMR exome
AF:
0.130
Gnomad4 ASJ exome
AF:
0.229
Gnomad4 EAS exome
AF:
0.227
Gnomad4 SAS exome
AF:
0.101
Gnomad4 FIN exome
AF:
0.255
Gnomad4 NFE exome
AF:
0.233
Gnomad4 OTH exome
AF:
0.207
GnomAD4 genome
AF:
0.167
AC:
25361
AN:
152224
Hom.:
2668
Cov.:
33
AF XY:
0.167
AC XY:
12408
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.0423
Gnomad4 AMR
AF:
0.168
Gnomad4 ASJ
AF:
0.227
Gnomad4 EAS
AF:
0.210
Gnomad4 SAS
AF:
0.100
Gnomad4 FIN
AF:
0.255
Gnomad4 NFE
AF:
0.225
Gnomad4 OTH
AF:
0.189
Alfa
AF:
0.210
Hom.:
5404
Bravo
AF:
0.158
Asia WGS
AF:
0.158
AC:
550
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 33% of patients studied by a panel of primary immunodeficiencies. Number of patients: 31. Only high quality variants are reported. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
13
DANN
Benign
0.94
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8722; hg19: chr1-234744250; COSMIC: COSV64014695; COSMIC: COSV64014695; API